[Importance of hyperammoniemia of the renal origin in the pathogenesis of hepatic coma released in cirrhotic patients by diuretics generating hypokaliemia].
作者信息
Imler M, Bockel R, Peter B, Kieny R, Stahl J
出版信息
Pathol Biol (Paris). 1969 Jan;17(1):5-19.
PMID:4895969
Abstract
摘要
相似文献
1
2
The complications of diuretic therapy in patients with cirrhosis.肝硬化患者利尿治疗的并发症
Ann N Y Acad Sci. 1966 Nov 22;139(2):497-505. doi: 10.1111/j.1749-6632.1966.tb41223.x.
3
Electrolyte disturbances resulting from diuretic therapy.利尿治疗引起的电解质紊乱。
Tex Med. 1973 Jul;69(7):83-7.
4
[Diuretics in cirrhosis. Accidents. Indications].[肝硬化中的利尿剂。不良反应。适应证]
Presse Med (1893). 1969 Mar 29;77(16):575-8.
5
Total body composition in cirrhotic patients with metabolic alkalosis, hypokalemia, hyperammoniemia, and portacaval shunt.患有代谢性碱中毒、低钾血症、高氨血症和门腔分流的肝硬化患者的全身成分
Am J Surg. 1969 Jan;117(1):85-90. doi: 10.1016/0002-9610(69)90289-x.
6
Diuretic drug therapy of edema.水肿的利尿药物治疗
Med Clin North Am. 1971 Mar;55(2):359-72. doi: 10.1016/s0025-7125(16)32525-1.
7
8
[Reversible hepatic encephalopathy provoked by diuretics].[利尿剂诱发的可逆性肝性脑病]
Eur J Toxicol. 1971 Jul-Aug;4(4):323-7.
9
Amiloride. A potassium-sparing natriuretic agent.氨氯吡咪。一种保钾利尿钠药。
Circulation. 1968 Jan;37(1):45-53. doi: 10.1161/01.cir.37.1.45.
10
Complications from diuretic therapy with ethacrynic acid and furosemide.依他尼酸和呋塞米利尿治疗的并发症。
South Med J. 1971 Jul;64(7):869-72. doi: 10.1097/00007611-197107000-00020.
Zotero 插件